{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer's disease (AD)", "Antioxidant", "Beta amyloid (A\u03b2)", "Caenorhabditis elegans", "Glycation", "Neuroinflammation"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27693453", "DateCompleted": {"Year": "2018", "Month": "01", "Day": "31"}, "DateRevised": {"Year": "2020", "Month": "05", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "09", "Day": "29"}], "ELocationID": ["10.1016/j.neuint.2016.09.014", "S0197-0186(16)30347-3"], "Language": ["eng"], "Journal": {"ISSN": "1872-9754", "JournalIssue": {"Volume": "100", "PubDate": {"Year": "2016", "Month": "Nov"}}, "Title": "Neurochemistry international", "ISOAbbreviation": "Neurochem Int"}, "ArticleTitle": "Development of a neuroprotective potential algorithm for medicinal plants.", "Pagination": {"StartPage": "164", "EndPage": "177", "MedlinePgn": "164-177"}, "Abstract": {"AbstractText": ["Medicinal plants are promising candidates for Alzheimer's disease (AD) research but there is lack of systematic algorithms and procedures to guide their selection and evaluation. Herein, we developed a Neuroprotective Potential Algorithm (NPA) by evaluating twenty-three standardized and chemically characterized Ayurvedic medicinal plant extracts in a panel of bioassays targeting oxidative stress, carbonyl stress, protein glycation, amyloid beta (A\u03b2) fibrillation, acetylcholinesterase (AChE) inhibition, and neuroinflammation. The twenty-three herbal extracts were initially evaluated for: 1) total polyphenol content (Folin-Ciocalteu assay), 2) free radical scavenging capacity (DPPH assay), 3) ferric reducing antioxidant power (FRAP assay), 4) reactive carbonyl species scavenging capacity (methylglyoxal trapping assay), 5) anti-glycative effects (BSA-fructose, and BSA-methylglyoxal assays) and, 6) anti-A\u03b2 fibrillation effects (thioflavin-T assay). Based on assigned index scores from the initial screening, twelve extracts with a cumulative NPA score \u226540 were selected for further evaluation for their: 1) inhibitory effects on AChE activity, 2) in\u00a0vitro anti-inflammatory effects on murine BV-2 microglial cells (Griess assay measuring levels of lipopolysaccharide-induced nitric oxide species), and 3) in\u00a0vivo neuroprotective effects on Caenorhabditis elegans post induction of A\u03b2<sub>1-42</sub> induced neurotoxicity and paralysis. Among these, four extracts had a cumulative NPA score \u226560 including Phyllanthus emblica (amla; Indian gooseberry), Mucuna pruriens (velvet bean), Punica granatum (pomegranate) and Curcuma longa (turmeric; curcumin). These extracts also showed protective effects on H<sub>2</sub>O<sub>2</sub> induced cytotoxicity in differentiated cholinergic human neuronal SH-SY5Y and murine BV-2 microglial cells and reduced tau protein levels in the SH-SY5Y neuronal cells. While published animal data support the neuroprotective effects of several of these Ayurvedic medicinal plant extracts, some remain unexplored for their anti-AD potential. Therefore, the NPA may be utilized, in part, as a strategy to help guide the selection of promising medicinal plant candidates for future AD-based research using animal models."], "CopyrightInformation": "Copyright \u00a9 2016 Elsevier Ltd. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Rhode Island, Kingston, RI 02881, USA."}], "LastName": "Liu", "ForeName": "Weixi", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioactive Botanical Research Laboratory, Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA."}], "LastName": "Ma", "ForeName": "Hang", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioactive Botanical Research Laboratory, Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA."}], "LastName": "DaSilva", "ForeName": "Nicholas A", "Initials": "NA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioactive Botanical Research Laboratory, Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA."}], "LastName": "Rose", "ForeName": "Kenneth N", "Initials": "KN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioactive Botanical Research Laboratory, Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA."}], "LastName": "Johnson", "ForeName": "Shelby L", "Initials": "SL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioactive Botanical Research Laboratory, Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA."}], "LastName": "Zhang", "ForeName": "Lu", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioactive Botanical Research Laboratory, Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA."}], "LastName": "Wan", "ForeName": "Chunpeng", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Rhode Island, Kingston, RI 02881, USA. Electronic address: jdain@chm.uri.edu."}], "LastName": "Dain", "ForeName": "Joel A", "Initials": "JA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioactive Botanical Research Laboratory, Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA; George & Anne Ryan Institute for Neuroscience, University of Rhode Island, Kingston, RI 02881, USA. Electronic address: nseeram@uri.edu."}], "LastName": "Seeram", "ForeName": "Navindra P", "Initials": "NP"}], "GrantList": [{"GrantID": "P20 GM103430", "Acronym": "GM", "Agency": "NIGMS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Neurochem Int", "NlmUniqueID": "8006959", "ISSNLinking": "0197-0186"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Amyloid beta-Peptides"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "BBX060AN9V", "NameOfSubstance": "Hydrogen Peroxide"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Algorithms"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Amyloid beta-Peptides"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Hydrogen Peroxide"}, {"QualifierName": ["drug effects"], "DescriptorName": "Microglia"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neurotoxicity Syndromes"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["metabolism"], "DescriptorName": "Plants, Medicinal"}], "CoiStatement": "Conflict of Interest. The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ahmed AH, Subaiea GM, Eid A, Li L, Seeram NP and Zawia NH, 2014. Pomegranate extract modulates processing of amyloid-\u03b2 precursor protein in an aged Alzheimer\u2019s disease animal model. Curr. Alzheimer Res. 11, 834\u2013843.", "ArticleIdList": ["25274111"]}, {"Citation": "Ahmed N, Ahmed U, Thornalley PJ, Hager K, Fleischer G, M\u00fcnch G, 2005. Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer\u2019s disease and link to cognitive impairment. J. Neurochem. 92, 255\u2013263.", "ArticleIdList": ["15663474"]}, {"Citation": "Ashwlayan VD, Singh R 2011. Reversal effect of Phyllanthus emblica (Euphorbiaceae) Rasayana on memory deficits in mice. Int. J. Appl. Pharm, 3, 10\u201315."}, {"Citation": "Alzheimer\u2019s Association, 2015. 2015 Alzheimer\u2019s disease facts and figures. Alzheimers & Dement. 11, 332\u2013384.", "ArticleIdList": ["25984581"]}, {"Citation": "Birks J, 2006. Cholinesterase inhibitors for Alzheimer\u2019s disease. Cochrane. Database Syst. Rev. 25, CD005593.", "ArticleIdList": ["PMC9006343", "16437532"]}, {"Citation": "Birks J, Melzer D, Beppu H, 2000. Donepezil for mild and moderate Alzheimer\u2019s disease. Cochrane. Database Syst. Rev. 4, CD001190.", "ArticleIdList": ["11034704"]}, {"Citation": "Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, Sheline YI, Klunk WE, Mathis CA, Morris JC, Mintun MA, 2005. Molecular, structural, and functional characterization of Alzheimer\u2019s disease: evidence for a relationship between default activity, amyloid, and memory. J. Neurosci. 25, 7709\u20137717.", "ArticleIdList": ["PMC6725245", "16120771"]}, {"Citation": "Butterfield DA, 2002. Amyloid beta-peptide (1\u201342)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer\u2019s disease brain. A review. Free Radic. Res. 36, 1307\u20131313.", "ArticleIdList": ["12607822"]}, {"Citation": "Chandra V, Pandav R, Dodge HH, Johnston JM, Belle SH, DeKosky ST, Ganguli M, 2001. Incidence of Alzheimer\u2019s disease in a rural community in India: the Indo-US study. Neurology 57, 985\u2013989.", "ArticleIdList": ["11571321"]}, {"Citation": "Chen K, Kazachkov M, Yu PH, 2007. Effect of aldehydes derived from oxidative deamination and oxidative stress on beta-amyloid aggregation; pathological implications to Alzheimer\u2019s disease. J. Neural. Transm. (Vienna) 114, 835\u2013839.", "ArticleIdList": ["17401529"]}, {"Citation": "Chen K, Maley J, Yu PH, 2006. Potential implications of endogenous aldehydes in \u03b2\u2010amyloid misfolding, oligomerization and fibrillogenesis. J. Neurochem. 99, 1413\u20131424.", "ArticleIdList": ["17074066"]}, {"Citation": "Choi D-Y, Lee Y-J, Hong JT, Lee H-J, 2012. Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer\u2019s disease. Brain Res. Bull. 87, 144\u2013153.", "ArticleIdList": ["22155297"]}, {"Citation": "Christen Y, 2000. Oxidative stress and Alzheimer disease. Am. J. Clin. Nutr. 71, 621s\u2013629s.", "ArticleIdList": ["10681270"]}, {"Citation": "Citron M, 2010. Alzheimer\u2019s disease: strategies for disease modification. Nat. Rev. Drug Discov. 9, 387\u2013398.", "ArticleIdList": ["20431570"]}, {"Citation": "Dhanasekaran M, Holcomb LA, Hitt AR, Tharakan B, Porter JW, Young KA, Manyam BV 2009. Centella asiatica extract selectively decreases amyloid \u03b2 levels in hippocampus of Alzheimer\u2019s disease animal model. Phytother. Res, 23, 14\u201319.", "ArticleIdList": ["19048607"]}, {"Citation": "Donahue JE, Flaherty SL, Johanson CE, Duncan JA, Silverberg GD, Miller MC, Tavares R, Yang W, Wu Q, Sabo E, Hovanesian V, Stopa EG, 2006. RAGE, LRP-1, and amyloid-beta protein in Alzheimer\u2019s disease. Acta Neuropathol. 112, 405\u2013415.", "ArticleIdList": ["16865397"]}, {"Citation": "Ebrahimi A and Schluesener H, 2012. Natural polyphenols against neurodegenerative disorders: potentials and pitfalls. Ageing Res. Rev. 11, 329\u2013345.", "ArticleIdList": ["22336470"]}, {"Citation": "Ellman GL, Courtney KD, Andres V and Featherstone RM, 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88\u201395.", "ArticleIdList": ["13726518"]}, {"Citation": "Eikelenboom P, Bate C, Van Gool W, Hoozemans J, Rozemuller J, Veerhuis R, Williams A, 2002. Neuroinflammation in Alzheimer\u2019s disease and prion disease. Glia 40, 232\u2013239.", "ArticleIdList": ["12379910"]}, {"Citation": "Eikelenboom P, Veerhuis R, Scheper W, Rozemuller A, Van Gool W, Hoozemans J, 2006. The significance of neuroinflammation in understanding Alzheimer\u2019s disease. J. Neural Transm. 113, 1685\u20131695.", "ArticleIdList": ["17036175"]}, {"Citation": "Feng Y, Wang X-P, Yang S-G, Wang Y-J, Zhang X, Du X-T, Sun X-X, Zhao M, Huang L, Liu R-T, 2009. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation. Neurotoxicology 30, 986\u2013995.", "ArticleIdList": ["19744518"]}, {"Citation": "G\u00f3mez-Ramos A, D\u00edaz-Hern\u00e1ndez M, Cuadros R, Hern\u00e1ndez F and Avila J, 2006. Extracellular tau is toxic to neuronal cells. FEBS Lett. 580, 4842\u20134850.", "ArticleIdList": ["16914144"]}, {"Citation": "Ittner LM, G\u00f6tz J, 2011. Amyloid-\u03b2 and tau--a toxic pas de deux in Alzheimer\u2019s disease. Nat. Rev. Neurosci. 12, 65\u201372.", "ArticleIdList": ["21193853"]}, {"Citation": "Jean-Gilles D, Li L, Ma H, Yuan T, Chichester CO, Seeram NP, 2012. Anti-inflammatory effects of polyphenolic-enriched red raspberry extract in an antigen-induced arthritis rat model. J. Agric. Food Chem. 60, 5755\u20135762.", "ArticleIdList": ["PMC3306488", "22111586"]}, {"Citation": "Katzenschlager R, Evans A, Manson A, Patsalos PN, Ratnaraj N, Watt H, 2004. Mucuna pruriens in Parkinson\u2019s disease: a double blind clinical and pharmacological study. J. Neurol. Neurosurg. Psychiatry. 75,1672\u20131677.", "ArticleIdList": ["PMC1738871", "15548480"]}, {"Citation": "Kosaraju J, Madhunapantula SV, Chinni S, Khatwal RB, Dubala A, Nataraj SKM, & Basavan D 2014. Dipeptidyl peptidase-4 inhibition by Pterocarpus marsupium and Eugenia jambolana ameliorates streptozotocin induced Alzheimer\u2019s disease. Behav. Brain Res, 267, 55\u201365.", "ArticleIdList": ["24667360"]}, {"Citation": "Li F, Gong Q, Dong H, Shi J, 2012. Resveratrol, a neuroprotective supplement for Alzheimer\u2019s disease. Curr. Pharm. Des. 18, 27\u201333.", "ArticleIdList": ["22211686"]}, {"Citation": "Li X-H, Du L-L, Cheng X-S, Jiang X, Zhang Y, Lv B-L, Liu R, Wang J-Z, Zhou X-W, 2013. Glycation exacerbates the neuronal toxicity of \u03b2-amyloid. Cell Death Dis. 4, e673.", "ArticleIdList": ["PMC3698547", "23764854"]}, {"Citation": "Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM, 2001. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 21, 8370\u20138377.", "ArticleIdList": ["PMC6762797", "11606625"]}, {"Citation": "Lin MT, Beal MF, 2006. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787\u2013795.", "ArticleIdList": ["17051205"]}, {"Citation": "Liu W, Ma H, Frost L, Yuan T, Dain JA, Seeram NP, 2014. Pomegranate phenolics inhibit formation of advanced glycation endproducts by scavenging reactive carbonyl species. Food & Funct. 5, 2996\u20133004.", "ArticleIdList": ["25233108"]}, {"Citation": "Ma H, DaSilva NA, Liu W, Nahar PP, Wei Z, Liu Y, Pham PT, Crews R, Vattem DA, Slitt AL Shaikh ZA, Seeram NP 2016. Effects of a standardized phenolic-enriched maple syrup extract on \u03b2-amyloid aggregation, neuroinflammation in microglial and neuronal cells, and \u03b2-amyloid induced neurotoxicity in Caenorhabditis elegans. Neurochem. Res. doi:10.1007/s11064-016-1998-6", "ArticleIdList": ["10.1007/s11064-016-1998-6", "PMC5819752", "27418278"]}, {"Citation": "Ma H, Liu W, Frost L, Kirschenbaum LJ, Dain JA, Seeram NP, 2016. Glucitol-core containing gallotannins inhibit the formation of advanced glycation end-products mediated by their antioxidant potential. Food & Funct. DOI: 10.1039/C6FO00169F", "ArticleIdList": ["10.1039/C6FO00169F", "PMC4871730", "27101975"]}, {"Citation": "Ma H, Liu W, Frost L, Wang L, Kong L, Dain JA, Seeram NP, 2015. The hydrolyzable gallotannin, penta-O-galloyl-\u03b2-D-glucopyranoside, inhibits the formation of advanced glycation endproducts by protecting protein structure. Mol. Biosyst. 11, 1338\u20131347.", "ArticleIdList": ["25789915"]}, {"Citation": "Maksimovi\u0107 Z, Malen\u010di\u0107 \u0110 and Kova\u010devi\u0107 N, 2005. Polyphenol contents and antioxidant activity of Maydis stigma extracts. Bioresour. Technol. 96, 873\u2013877.", "ArticleIdList": ["15627557"]}, {"Citation": "Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, Yarasheski KE, Bateman RJ, 2010. Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease. Science 330, 1774.", "ArticleIdList": ["PMC3073454", "21148344"]}, {"Citation": "M\u00fcnch G, Westcott B, Menini T, Gugliucci A, 2012. Advanced glycation endproducts and their pathogenic roles in neurological disorders. Amino Acids 42, 1221\u20131236.", "ArticleIdList": ["20949363"]}, {"Citation": "Nahar PP, Driscoll MV, Li L, Slitt AL and Seeram NP, 2014. Phenolic mediated anti-inflammatory properties of a maple syrup extract in RAW 264.7 murine macrophages. J. Funct. Foods, 6,126\u2013136."}, {"Citation": "Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C, 2014. Potential for primary prevention of Alzheimer\u2019s disease: an analysis of population-based data. Lancet Neurol. 13, 788\u2013794.", "ArticleIdList": ["25030513"]}, {"Citation": "Palop JJ, Mucke L, 2010. Amyloid-beta-induced neuronal dysfunction in Alzheimer\u2019s disease: from synapses toward neural networks. Nat. Neurosci. 13, 812\u2013818.", "ArticleIdList": ["PMC3072750", "20581818"]}, {"Citation": "Picklo MJ, Montine TJ, Amarnath V, Neely MD, 2002. Carbonyl toxicology and Alzheimer\u2019s disease. Toxicol. Appl. Pharmacol. 184, 187\u2013197.", "ArticleIdList": ["12460747"]}, {"Citation": "Pratic\u00f2 D, 2008. Evidence of oxidative stress in Alzheimer\u2019s disease brain and antioxidant therapy: lights and shadows. Ann. NY Acad. Sci. 1147, 70\u201378.", "ArticleIdList": ["19076432"]}, {"Citation": "Reitz C, Mayeux R, 2014. Alzheimer\u2019s disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem. Pharmacol. 88, 640\u2013651.", "ArticleIdList": ["PMC3992261", "24398425"]}, {"Citation": "Ringman JM, Frautschy SA, Cole GM, Masterman DL, & Cummings JL 2005. A potential role of the curry spice curcumin in Alzheimer\u2019s disease. Curr. Alz. Res. 2, 131\u2013136.", "ArticleIdList": ["PMC1702408", "15974909"]}, {"Citation": "Seeram NP, Aviram M, Zhang Y, Henning SM, Feng L, Dreher M, Heber D, 2008. Comparison of antioxidant potency of commonly consumed polyphenol-rich beverages in the United States. J. Agric. Food Chem. 56, 1415\u20131422.", "ArticleIdList": ["18220345"]}, {"Citation": "Singh M, Arseneault M, Sanderson T, Murthy V and Ramassamy C, 2008. Challenges for research on polyphenols from foods in Alzheimer\u2019s disease: bioavailability, metabolism, and cellular and molecular mechanisms. J. Agric. Food Chem. 56, 4855\u20134873.", "ArticleIdList": ["18557624"]}, {"Citation": "Smith MA, Rottkamp CA, Nunomura A, Raina AK, Perry G, 2000. Oxidative stress in Alzheimer\u2019s disease. Biochim. Biophys. Acta (BBA)-Mol. Basis Dis. 1502, 139\u2013144.", "ArticleIdList": ["10899439"]}, {"Citation": "Solanki I, Parihar P, Parihar MS, 2016. Neurodegenerative diseases: From available treatments to prospective herbal therapy. Neurochem. Int. 95, 100\u2013108.", "ArticleIdList": ["26550708"]}, {"Citation": "Srikanth V, Maczurek A, Phan T, Steele M, Westcott B, Juskiw D, M\u00fcnch G, 2011. Advanced glycation endproducts and their receptor RAGE in Alzheimer\u2019s disease. Neurobiol. Aging 32, 763\u2013777.", "ArticleIdList": ["19464758"]}, {"Citation": "Steele ML, Truong J, Govindaraghavan S, Ooi L, Sucher NJ, M\u00fcnch G, 2013. Cytoprotective properties of traditional Chinese medicinal herbal extracts in hydrogen peroxide challenged human U373 astroglia cells. Neurochem. Int. 62, 522\u2013529.", "ArticleIdList": ["22982670"]}, {"Citation": "Sun J, Liu W, Ma H, Marais JP, Khoo C, Dain JA, Rowley DC, Seeram NP, 2016. Effect of cranberry (Vaccinium macrocarpon) oligosaccharides on the formation of advanced glycation end-products. J. Berry Res, 1\u201310.", "ArticleIdList": ["PMC5467715", "28649289"]}, {"Citation": "Thornalley PJ, 2003. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch. Biochem. Biophys. 419, 31\u201340.", "ArticleIdList": ["14568006"]}, {"Citation": "Timmermann L, Van der Giessen R, Lees AJ.Koo EH, Lansbury PT, Kelly JW, 1999. Amyloid diseases: abnormal protein aggregation in neurodegeneration. Proc. Natl. Acad. Sci. USA 96, 9989\u20139990.", "ArticleIdList": ["PMC33726", "10468546"]}, {"Citation": "Tsai PJ, McIntosh J, Pearce P, Camden B and Jordan BR, 2002. Anthocyanin and antioxidant capacity in Roselle (Hibiscus sabdariffa L.) extract. Food Res. Int. 35, 351\u2013356."}, {"Citation": "Vas CJ, Pinto C, Panikker D, Noronha S, Deshpande N, Kulkarni L, Sachdeva S, 2001. Prevalence of dementia in an urban Indian population. Int. Psychogeriatr. 13, 439\u2013450.", "ArticleIdList": ["12003250"]}, {"Citation": "Venigalla M, Sonego S, Gyengesi E, Sharman MJ, M\u00fcnch G, 2016. Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer\u2019s disease. Neurochem. Int. 95, 63\u201374.", "ArticleIdList": ["26529297"]}, {"Citation": "Vicente Miranda H, Outeiro TF, 2010. The sour side of neurodegenerative disorders: the effects of protein glycation. J. Pathol. 221, 13\u201325.", "ArticleIdList": ["20186922"]}, {"Citation": "Wang D, Ho L, Faith J, Ono K, Janle EM, Lachcik PJ, Cooper BR, Jannasch AH, D\u2019Arcy BR, Williams BA and Ferruzzi MG, 2015. Role of intestinal microbiota in the generation of polyphenol-derived phenolic acid mediated attenuation of Alzheimer\u2019s disease \u03b2-amyloid oligomerization. Mol. Nutr. Food Res. 59,1025\u20131040.", "ArticleIdList": ["PMC4498582", "25689033"]}, {"Citation": "Wang J, Bi W, Cheng A, Freire D, Vempati P, Zhao W, Gong B, Janle EM, Chen TY, Ferruzzi MG and Schmeidler J, 2014. Targeting multiple pathogenic mechanisms with polyphenols for the treatment of Alzheimer\u2019s disease-experimental approach and therapeutic implications. Front. Aging Neurosci. 6, 42.", "ArticleIdList": ["PMC3954102", "24672477"]}, {"Citation": "Wu C-H, Yen G-C, 2005. Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts. J. Agric. Food Chem. 53, 3167\u20133173.", "ArticleIdList": ["15826074"]}, {"Citation": "Yuan T, Ma H, Liu W, Niesen DB, Shah N, Crews R, Rose KN, Vattem DA, Seeram NP, 2015. Pomegranate\u2019s neuroprotective effects against Alzheimer\u2019s disease are mediated by urolithins, its ellagitannin-gut microbial derived metabolites. ACS Chem. Neurosci. 7, 26\u201333.", "ArticleIdList": ["26559394"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "4", "Day": "27"}, {"Year": "2016", "Month": "9", "Day": "22"}, {"Year": "2016", "Month": "9", "Day": "28"}, {"Year": "2016", "Month": "10", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "2", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "10", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "30"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27693453", "NIHMS1565855", "PMC7191989", "10.1016/j.neuint.2016.09.014", "S0197-0186(16)30347-3"]}}], "PubmedBookArticle": []}